| Literature DB >> 26726018 |
Moo-Sung Han1, Jong-Nyeo Kim1, Eun-Ok Jeon1, Hae-Rim Lee1, Bon-Sang Koo1, Kyeong-Cheol Min1, Seung-Baek Lee1, Yeon-Ji Bae1, Jong-Suk Mo1, Sun-Hyung Cho1, Hye-Sun Jang2, In-Pil Mo1.
Abstract
Infectious coryza (IC) is an infectious disease caused by Avibacterium (Av.) paragallinarum. IC is known to cause economic losses in the poultry industry via decreased egg production in layers. Between 2012 and 2013, Av. paragallinarum was isolated from seven chicken farms by Chungbuk National University. We identified Av. paragallinarum, the causative pathogen of IC by polymerase chain reaction (PCR) and serovar serotype A, by multiplex PCR. Antibiotic sensitivity tests indicated that a few field-isolated strains showed susceptibility to erythromycin, gentamicin, lincomycin, neomycin, oxytetracycline, spectinomycin, and tylosin. A serological survey was conducted to evaluate the number of flocks that were positive for Av. paragallinarum by utilizing a HI test to determine the existence of serovar A. Serological surveys revealed high positivity rates of 86.4% in 2009, 78.9% in 2010, 70.0% in 2011, and 69.6% in 2012. We also challenged specific pathogen-free chickens with isolated domestic strains, ADL121286 and ADL121500, according to the measured efficacy of the commercial IC vaccine, PoulShot Coryza. We confirmed the effectiveness of the vaccine based on relief of clinical signs and a decreased re-isolation rate of ADL121500 strain. Our results indicate IC is currently prevalent in Korea, and that the commercial vaccine is effective at protecting against field strains.Entities:
Keywords: Avibacterium paragallinarum; infectious coryza; infectious coryza vaccine; serologic survey
Mesh:
Substances:
Year: 2016 PMID: 26726018 PMCID: PMC5037299 DOI: 10.4142/jvs.2016.17.3.323
Source DB: PubMed Journal: J Vet Sci ISSN: 1229-845X Impact factor: 1.672
Summary of antibiotic sensitivity test against seven field isolates of Avibacterium paragallinarum using the disk diffusion test
Experimental design for the evaluation of efficacy of commercial infectious coryza (IC) vaccine (PoulShot Coryza) in the specific pathogen-free (SPF) chicken
*Intramuscular injection of 1.0 mL of vaccine containing 108 CFU/mL at 40 days of age. †Challenged by nasal inoculation of 0.2 mL of 108 CFU/mL at 54 days of age.
Summary of IC field strain in which Avibacterium paragallinarum was isolated
*Common necropsy lesions: swelling of infraorbital sinus, edema of the surrounding tissues sometimes extending the wattles, hyperemia in conjunctiva.
Serological survey for serovar A of IC in chicken flocks with a history of distress or decreased egg production using the hemagglutination inhibition (HI) test
*Number of positive farms/total number of farms tested (positive rate). NT, not tested.
Evaluation of pathogenicity used by clinical signs and re-isolation rate in SPF chickens challenged with a field strain of Avibacterium paragallinarum
*Group A and C were vaccinated at 40 days of age; Group A and B were challenged with field strain of ADL121286 at 54 days of age; Group C and D were challenged with field strain of ADL121500 at 54 days of age; Group E was the control group. †Average score of severity of clinical signs on a daily basis; Average score within row followed by dissimilar superscript letters are significantly different at p ≤ 0.05. ‡Number of positive samples/total number of samples tested (positive rate).
Comparison of HI antibody titer for serovar A after vaccination with commercial vaccine, PoulShot Coryza, at the age of 40 days and challenged with field strain of Avibacterium paragallinarum at the age of 54 days
*Arithmetic mean titer. Results are expressed as the reciprocal of the highest dilution for which there was no visible agglutination. dpv, days post vaccination; dpc, days post challenge.